|
Basic Characteristics of Mutations
|
|
Mutation Site
|
L83V |
|
Mutation Site Sentence
|
The rank orders of incidence of HPV 16 prototype and E6 variants were as follows: D25E (62%), the prototype (17%), E113D (9%), L83V (6%) in case subjects; the prototype (71%), D25E (23%), L83V/E113D (7%) in control subjects. |
|
Mutation Level
|
Amino acid level |
|
Mutation Type
|
Nonsynonymous substitution |
|
Gene/Protein/Region
|
E6 |
|
Standardized Encoding Gene
|
E6
|
|
Genotype/Subtype
|
HPV16 |
|
Viral Reference
|
-
|
|
Functional Impact and Mechanisms
|
|
Disease
|
Uterine Cervical Neoplasms
|
|
Immune
|
- |
|
Target Gene
|
-
|
|
Clinical and Epidemiological Correlations
|
|
Clinical Information
|
Y |
|
Treatment
|
- |
|
Location
|
China |
|
Literature Information
|
|
PMID
|
19699050
|
|
Title
|
Human papillomavirus type 16 E6 gene variations in Chinese population
|
|
Author
|
Cai HB,Chen CC,Ding XH
|
|
Journal
|
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
|
|
Journal Info
|
2010 Feb;36(2):160-3
|
|
Abstract
|
OBJECTIVE: To identify genetic variants in the E6 gene of HPV 16 and to examine the association between these variants and cervical cancer development. METHODS: Cervical samples were collected from 72 patients with cervical cancer and 72 age-matched control subjects, all from Hubei Province, China. HPV 16 sequence was detected with E6 gene-specific polymerase chain reaction, and variants were identified by DNA sequencing. RESULTS: HPV 16 was detected in 81% of the patients and 43% of control subjects, respectively. The rank orders of incidence of HPV 16 prototype and E6 variants were as follows: D25E (62%), the prototype (17%), E113D (9%), L83V (6%) in case subjects; the prototype (71%), D25E (23%), L83V/E113D (7%) in control subjects. The odds ratio of HPV 16 E6 variant was higher than that of prototype (RR=11.73, 95% CI=4.18-32.94, P=0.0001). CONCLUSION: The D25 E variant is the most prevalent E6 genomic variant in Hubei, China. The presence of HPV 16 E6 variant in cervical intraepithelial neoplasia (CIN) lesions may serve as a useful predictor of clinical outcome of the disease.
|
|
Sequence Data
|
-
|
|
|